Ramón
Lecumberri Villamediana
Consultor Médico
Gregorio
Rabago Juan Aracil
Consultor Médico
Gregorio Rabago Juan Aracil-rekin lankidetzan egindako argitalpenak (2)
2017
-
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43